Toggle Dropdown
Announcements
Projects
News & Events
Welcome guest
Log in
Loading
Loading...
https://www.modernretina.com/view/olix-pharmaceuticals-announces-positive-results-of-phase-1-study-of-safety-and-tolerability-of-olx10212
0
0
Research results: OliX Pharmaceuticals announces positive results of phase 1 safety and tolerability results of OLX10212 for AMD - Ophthalmology Times Europe
+ 12 more
12/13/23 at 6:25am
Organization
Modernretina.com
Author
Sydney M Crago
34 words
0
Comments
The study results will help to identify dosing levels for future clinical trials
Pharmaceuticals & Biotech
Health
Pharmacy
OliX Pharmaceuticals
dosing levels
OLX10212
AMD - Ophthalmology Times Europe
You are the first to view
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...